Efficacy of Rituximab in Refractory Generalized anti-AChR Myasthenia Gravis-Reference-Cited by-同舟云学术

Efficacy of Rituximab in Refractory Generalized anti-AChR Myasthenia Gravis

Published:2018-05-29 Issue:2 Volume:5 Page:241-249
ISSN:2214-3599
Container-title:Journal of Neuromuscular Diseases
language:
Short-container-title:JND

Author:

Landon-Cardinal Océane¹,Friedman Diane²,Guiguet Marguerite³,Laforêt Pascal⁴,Heming Nicholas²,Salort-Campana Emmanuelle⁵,Jouen Fabienne⁶,Allenbach Yves¹,Boyer Olivier⁶,Chatenoud Lucienne⁷,Eymard Bruno⁴,Sharshar Tarek²,Benveniste Olivier¹

Affiliation:

1. AP-HP, Hôpital Pitié-Salpêtrière, Department of Internal Medicine and ClinicalImmunology, Inflammation-Immunopathology-Biotherapy Department (I2B), East Paris Neuromuscular Diseases Reference Center, Inserm U974, Sorbonne Université, Paris 6, Paris, France

2. Department of IntensiveCare, Raymond Poincare University Hospital, Garches, France

3. Sorbonne Université, UPMC UnivParis 06, INSERM, Institut Pierre Louis d’Epidemiologie et de Santé Publique (IPLESP UMRS 1136), F75013, Paris, France

4. AP-HP, Hôpital Pitié-Salpêtrière, Department of Neurology, EastParis Neuromuscular Diseases Reference Center, Université Pierre et Marie Curie, Paris 6, Paris, France

5. APHM, Hôpital la Timone, Centre de Référence des Maladies Neuromusculaires, Marseille, France

6. Rouen University Hospital, Department of Immunology, Inserm U905, NormandieUniv, IRIB, Rouen, France

7. Université Paris Descartes, Sorbonne Paris Cité, Paris, France, and INSERM U1151, CNRS UMR 8253, INEM Hôpital Necker-Enfants Malades, Paris, France

Publisher

IOS Press

Subject

Neurology (clinical),Neurology

Reference27 articles.

1. Efficacy and safety ofrituximab for myasthenia gravis: A systematic review andmeta-analysis;Iorio;J Neurol,2015

2. Management of myasthenia gravis;Saperstein;Seminar in Neurology,2004

3. A clinical therapeutic trial of cyclosporine in myastheniagravis;Tindall;Ann N Y Acad Sci,1993

4. Retrospective analysis of the use of cyclosporine in myastheniagravis;Ciafaloni;Neurology,2000

5. Preliminary results of a double-blind,randomized, placebo-controlled trial of cyclosporine in myasthenia gravis;Tindall;N Engl J Med,1987

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the depths of IgG4: insights into autoimmunity and novel treatments;Frontiers in Immunology;2024-04-18

2. Promising efficacy of Low-Dose rituximab in Muscle specific kinase antibody positive Myasthenia Gravis;Neuroscience Letters;2024-01

3. Clinical efficacy of anti-CD20 antibodies in neurological and neuromuscular diseases;Resistance to Anti-Cd20 Antibodies and Approaches for their Reversal;2024

4. Rituximab treatment in myasthenia gravis;Frontiers in Neurology;2023-10-02

5. Immunity following SARS-CoV-2 vaccination in autoimmune neurological disorders treated with rituximab or ocrelizumab;Frontiers in Immunology;2023-06-16